Jump to content

Clazakizumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rod57 (talk | contribs) at 00:52, 11 November 2009 (=). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

ALD518 a humanized monclonal antibody against interleukin-6.

Clinical trials

Cancer

Phase II trial for advanced cancer.[1]

Rheumatoid arthritis

Phase II trial for rheumatoid arthritis.[2]

References

  1. ^ http://www.boliven.com/clinical_trial/NCT00866970
  2. ^ http://clinicaltrials.gov/ct2/show/NCT00867516
Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Clazakizumab&oldid=325156725"